Home › Funds › Slocum, Gordon & Co LLP › ABBV

Slocum, Gordon & Co LLP position in ABBV

ABBVIE INC · Health Care

Slocum, Gordon & Co LLP reported holding 20,100 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$5.3M, representing 3.67% of its reported portfolio and ranking #7 among its reported holdings. Slocum, Gordon & Co LLP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)20.10K sh
Reported value held$5.26M
Portfolio Weight3.67%
First reportedQ3 2023
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Slocum, Gordon & Co LLP's ABBV position evolved

Slocum, Gordon & Co LLP first disclosed a stake in ABBV in Q3 2023 at 42,294 shares (US$6.3M). The position peaked in Q3 2024 at 40,174 shares, worth US$7.9M. Across 13 filings, Slocum, Gordon & Co LLP increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 20,100 shares valued at US$5.3M. Notable position changes include a 44% trim in Q1 2025 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 42.29K $6.30M New
Q4 2023 42.54K $6.59M Add
Q1 2024 42.51K $7.74M Hold
Q2 2024 42.46K $7.28M Hold
Q3 2024 40.17K $7.93M Reduce
Q4 2024 38.32K $6.81M Reduce
Q1 2025 21.40K $4.48M Reduce
Q2 2025 21.15K $3.93M Reduce
Q3 2025 21.11K $4.89M Hold
Q4 2025 21.02K $4.80M Hold
Q1 2026 20.47K $4.45M Reduce
Q2 2026 20.19K $5.08M Reduce
Q3 2026 20.10K $5.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Slocum, Gordon & Co LLP held ABBV?

Slocum, Gordon & Co LLP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Slocum, Gordon & Co LLP's current position in ABBV?

As of Q3 2026, Slocum, Gordon & Co LLP holds 20.10K shares of ABBV (ABBVIE INC), valued at $5.26M, representing 3.67% of its reported portfolio and ranking #7.

Has Slocum, Gordon & Co LLP been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Slocum, Gordon & Co LLP held unchanged its position in ABBV. The position peaked in Q3 2024 at 40.17K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.